fluoxetine and Uterine Cervical Neoplasms

fluoxetine has been researched along with Uterine Cervical Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hariharan, R; Krishnan, A; Nair, SA; Pillai, MR1

Other Studies

1 other study(ies) available for fluoxetine and Uterine Cervical Neoplasms

ArticleYear
Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1.
    Biochemical pharmacology, 2008, May-15, Volume: 75, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carrier Proteins; CDC2-CDC28 Kinases; Cell Line, Tumor; Cell Survival; Cyclin A; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclophosphamide; Female; Fibroblasts; Fluoxetine; G1 Phase; Humans; Resting Phase, Cell Cycle; RNA, Messenger; Tumor Cells, Cultured; Uterine Cervical Neoplasms

2008